Duke Clinical Research Institute, Durham, North Carolina 27715, USA.
J Am Coll Cardiol. 2010 May 4;55(18):1923-32. doi: 10.1016/j.jacc.2010.02.005.
We sought to create contemporary models for predicting mortality risk following percutaneous coronary intervention (PCI).
There is a need to identify PCI risk factors and accurately quantify procedural risks to facilitate comparative effectiveness research, provider comparisons, and informed patient decision making.
Data from 181,775 procedures performed from January 2004 to March 2006 were used to develop risk models based on pre-procedural and/or angiographic factors using logistic regression. These models were independently evaluated in 2 validation cohorts: contemporary (n = 121,183, January 2004 to March 2006) and prospective (n = 285,440, March 2006 to March 2007).
Overall, PCI in-hospital mortality was 1.27%, ranging from 0.65% in elective PCI to 4.81% in ST-segment elevation myocardial infarction patients. Multiple pre-procedural clinical factors were significantly associated with in-hospital mortality. Angiographic variables provided only modest incremental information to pre-procedural risk assessments. The overall National Cardiovascular Data Registry (NCDR) model, as well as a simplified NCDR risk score (based on 8 key pre-procedure factors), had excellent discrimination (c-index: 0.93 and 0.91, respectively). Discrimination and calibration of both risk tools were retained among specific patient subgroups, in the validation samples, and when used to estimate 30-day mortality rates among Medicare patients.
Risks for early mortality following PCI can be accurately predicted in contemporary practice. Incorporation of such risk tools should facilitate research, clinical decisions, and policy applications.
我们旨在建立预测经皮冠状动脉介入治疗(PCI)后死亡率的现代模型。
需要识别 PCI 的风险因素,并准确量化手术风险,以促进比较效果研究、提供者比较和患者知情决策。
使用逻辑回归,基于术前和/或血管造影因素,从 2004 年 1 月至 2006 年 3 月期间进行的 181775 例手术中开发风险模型。在两个验证队列中独立评估这些模型:现代队列(n=121183,2004 年 1 月至 2006 年 3 月)和前瞻性队列(n=285440,2006 年 3 月至 2007 年 3 月)。
总的来说,PCI 院内死亡率为 1.27%,范围从择期 PCI 的 0.65%到 ST 段抬高型心肌梗死患者的 4.81%。多个术前临床因素与院内死亡率显著相关。血管造影变量仅为术前风险评估提供了适度的增量信息。总体国家心血管数据注册(NCDR)模型以及简化的 NCDR 风险评分(基于 8 个关键术前因素)具有出色的判别能力(c 指数:分别为 0.93 和 0.91)。在验证样本中以及在用于估计 Medicare 患者 30 天死亡率时,这两种风险工具的判别和校准在特定患者亚组中得以保留。
在现代实践中,可以准确预测 PCI 后早期死亡率的风险。纳入此类风险工具应有助于研究、临床决策和政策应用。